Guidance for the Interpretation of Long-Acting Cabotegravir and Rilpivirine Concentrations Based on Real-World Therapeutic Drug Monitoring Data and Documented Failures.
Details
State: Public
Version: Final published version
License: CC BY-NC-ND 4.0
Serval ID
serval:BIB_E70DD8E56C37
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Guidance for the Interpretation of Long-Acting Cabotegravir and Rilpivirine Concentrations Based on Real-World Therapeutic Drug Monitoring Data and Documented Failures.
Journal
Open forum infectious diseases
ISSN
2328-8957 (Print)
ISSN-L
2328-8957
Publication state
Published
Issued date
02/2024
Peer-reviewed
Oui
Volume
11
Number
2
Pages
ofae023
Language
english
Notes
Publication types: Journal Article
Publication Status: epublish
Publication Status: epublish
Abstract
The interpretation of long-acting cabotegravir and rilpivirine concentrations is complicated by the lack of consensus on the threshold to consider. Building on real-world therapeutic drug monitoring data and documented virologic failures, this article provides a reappraisal of the existing thresholds and guidance for the interpretation of cabotegravir and rilpivirine concentrations.
Keywords
Infectious Diseases, Oncology, TDM, cabotegravir, guidance, long-acting, rilpivirine
Pubmed
Web of science
Open Access
Yes
Create date
23/01/2024 15:47
Last modification date
12/03/2024 8:08
Usage data
